WeVote
Log In

Bill

Bill

SB 1183

Relating to firefighting services; declaring an emergency.

2025 Regular Session Introduced by Court Boice and 2 co-sponsors

Regulates kratom to protect consumers: bans sales to anyone under 21, enforces CGMP labeling, a 5% retail tax, and penalties for violators.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · SB 1183

Summary — SB 1183: Kratom Consumer Protection Act (as included in provided document)

Note on source document: The file you provided contains text from multiple, unrelated measures (including Arizona landlord/tenant amendments and a Hawaii labeling provision). This summary isolates and summarizes the Kratom Consumer Protection Act text that appears in the document (labeled SB1183 / Illinois bill text introduced Jan. 24, 2025).

Purpose

The bill creates a Kratom Consumer Protection Act intended to regulate the manufacture, sale, labeling, and taxation of kratom leaf and kratom products to improve consumer safety, restrict youth access, and establish enforcement mechanisms and penalties for violations.

Key provisions and requirements

  • Age restriction: Prohibits selling, offering, providing, or distributing kratom leaf or kratom products to anyone under 21.
    • Online retailers/marketplaces must implement an age‑verification system.
  • Product composition limits:
    • Caps 7‑hydroxymitragynine at no more than 2% of a product’s alkaloid fraction.
    • Prohibits kratom products that contain synthesized or semi‑synthesized kratom alkaloids or constituents.
    • Prohibits kratom products adulterated with dangerous non‑kratom substances (including listed controlled substances).
  • Child safety: Bans producing, selling, or distributing kratom products that are “attractive to children” (e.g., shaped like humans/cartoons/animals or mimic recognizable candy).
  • Manufacturing standards:
    • Kratom products must be manufactured, packaged, labeled, and held in compliance with current good manufacturing practices for dietary supplements (21 CFR Part 111).
    • Processors selling into the state must be registered with the U.S. Food and Drug Administration.
  • Taxation and reporting:
    • Imposes a 5% retail tax on sales of kratom products (in addition to other taxes).
    • Retailers must file quarterly returns and pay tax by the 25th day of the month following the quarter.
    • Knowingly filing a false or incomplete return is a Class A misdemeanor.
    • Department of Revenue authorized to administer and enforce the tax and related provisions; certain provisions of existing tax acts are incorporated.
  • Enforcement & penalties:
    • Civil penalties for selling in violation: up to $5,000 for a first violation; up to $10,000 for a second violation.
    • Third and subsequent violations: fined minimum $10,000 up to $20,000 and prohibited from selling kratom products in the state for 3 years.
  • Definitions: The bill defines terms such as “kratom leaf,” “kratom leaf extract,” “kratom product,” “processor,” “synthesized” and “semi‑synthesized” kratom constituents, and “attractive to children.”
  • Repeal: The text states repeal of an existing Kratom Control Act (where applicable in the jurisdiction).

Who is affected

  • Retailers, online marketplaces, and brick‑and‑mortar sellers of kratom products
  • Manufacturers and processors of kratom products (must meet FDA registration and CGMP standards)
  • Consumers 21 and older (access limited for under‑21s)
  • Department of Revenue and public health/regulatory agencies (enforcement duties)
  • Businesses making products resembling candy or child‑oriented packaging will be restricted

Procedural / status notes

  • The included bill text shows it was filed/introduced in early 2025 (Illinois text dated Jan. 24, 2025, by Sen. Javier L. Cervantes). The document also notes a companion bill (HB 496).
  • The multipart source you provided also lists many legislative actions and committee referrals (readings, hearings, and committee movements). For a jurisdictionally precise status, consult the legislative website of the relevant state (the text appears to be the Illinois draft of SB1183).

If you want, I can:
- Produce a side‑by‑side of the bill’s compliance requirements versus current federal FDA practice;
- Draft a short compliance checklist for retailers or processors; or
- Verify current bill status and recent amendments on the official state legislative site.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.